(Q45871974)

17 December 2017

title

10-year safety follow-up in patients with local VEGF gene transfer to ischemic lower limb (English)

1 reference

17 December 2017

author

Seppo Ylä-Herttuala

5

1 reference

17 December 2017

author name string

K Muona

1

1 reference

17 December 2017

K Mäkinen

2

1 reference

17 December 2017

M Hedman

3

1 reference

17 December 2017

H Manninen

4

1 reference

17 December 2017

publication date

21 July 2011

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

19

1 reference

17 December 2017

issue

4

1 reference

17 December 2017

page(s)

392-395

1 reference

17 December 2017

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Alteration of splicing signals in a genomic/cDNA hybrid VEGF gene to modify the ratio of expressed VEGF isoforms enhances safety of angiogenic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Safety profile of plasmid/liposomes and virus vectors in clinical gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Vascular endothelial growth factor-induced angiogenic gene therapy in patients with peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Risks and benefits of gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Assessment of risks associated with cardiovascular gene therapy in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Points to consider for ethics committees in human gene therapy trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Cardiovascular gene therapy: current status and therapeutic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Orthopedic applications of gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Update on Some Epidemiologic Features of Intermittent Claudication: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

A stable prostacyclin analogue (iloprost) in the treatment of ischaemic ulcers of the lower limb. A Scandinavian-Polish placebo controlled, randomised multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Outcome of unreconstructed chronic critical leg ischaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Intravitreal adenoviral 15-lipoxygenase-1 gene transfer prevents vascular endothelial growth factor A-induced neovascularization in rabbit eyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Gene transfer as a tool to induce therapeutic vascular growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Increased revascularization efficacy after administration of an adenovirus encoding VEGF(121).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Restoration of coronary collateral growth in the Zucker obese rat: impact of VEGF and ecSOD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.109

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2011.109

1 reference

17 December 2017

Dimensions Publication ID

1002488558

0 references

1 reference

17 December 2017